Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: a systematic evaluation.

Saved in:
Bibliographic Details
Title: Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: a systematic evaluation.
Authors: Kyttaris VC; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Petri MA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Wallace DJ; Kao Autoimmunity Center, Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA., Rogers JL; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Busch H; Florida Arthritis Center-American Arthritis and Rheumatology Associates/Bendcare, Jupiter, Florida, USA., Daniel R; Bay Area Rheumatology, Clearwater, Florida, USA., Concoff A; Exagen, Carlsbad, California, USA., Taghavi S; Exagen, Carlsbad, California, USA., Warsi T; Exagen, Carlsbad, California, USA., Schleif C; Exagen, Carlsbad, California, USA., Alvarez C; Exagen, Carlsbad, California, USA., Partain BD; Exagen, Carlsbad, California, USA., O'Malley T; Exagen, Carlsbad, California, USA tomalley@exagen.com., Mahler M; Exagen, Carlsbad, California, USA.
Source: Lupus science & medicine [Lupus Sci Med] 2026 May 29; Vol. 13 (1). Date of Electronic Publication: 2026 May 29.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2053-8790
DOI:10.1136/lupus-2026-002002